{"text": "The safety and tolerability of antipsychotics in obese patients have been a\n\nconcern for researchers. Studies have reported higher rates of adverse events,\n\nsuch as weight gain, metabolic changes, and cardiovascular problems, in\n\nobese patients treated with antipsychotics (Kaplan et al., 2017).\n\nPotential Interactions with Other Medications\n\nObese patients taking antipsychotics may be at risk for interactions with other\n\nmedications, such as:\n\n   \u2022 Antidiabetic medications\n\n   \u2022 Cardiovascular medications", "embedding": []}